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Abstract
Background: Proteins linking intermediate filaments to other cytoskeletal components have
important functions in maintaining tissue integrity and cell shape.
Results: We found a set of monoclonal antibodies raised against specific human sarcomeric myosin
heavy chain (MyHC) isoforms labels cells in distinct regions of the mammalian epidermis. The
antigens co-localize with intermediate filament-containing structures. A slow MyHC-related antigen
is punctate on the cell surface and co-localizes with desmoplakin at desmosomal junctions of all
suprabasal epidermal layers from rat fœtal day 16 onwards, in the root sheath of the hair follicle
and in intercalated disks of cardiomyocytes. A fast MyHC-related antigen occurs in cytoplasmic
filaments in a subset of basal cells of skin epidermis and bulb, but not neck, of hair follicles. A fast
IIA MyHC-related antigen labels filaments of a single layer of cells in hair bulb. This 230 000 Mr
antigen co-purifies with keratin. No obvious candidate for any of the antigens appears in the
literature.
Conclusions: We describe a set of molecules that co-localize with intermediate filament in
specific cell subsets in epithelial tissues. These antigens presumably influence intermediate filament
structure or function.
Background
The diversity of molecules that generate the forces associ-
ated with tissue morphogenesis and function is large.
Three major classes of motor proteins are known: kinesins
and dyneins associated with microtubule-based move-
ments and myosins associated with actin-based motility
[1]. The myosin family is the best characterised among
motor proteins to date (for review see [2]). The archetypal
myosins are the myosin IIs that effect muscle contraction
[3] and perform a variety of functions in non-muscle cells,
including the regulation of cell motility [4]. Members of
the myosin II family consist of two heavy chains and four
light chains and function as actin-based ATP-driven
motors. The myosin II heavy chains (MyHCs) have a glob-
ular ATP- and actin-binding head which is capable of
independent force generation, and an elongated coiled
coil tail that allows MyHCs to dimerise and then aggregate
to form myosin filaments [1]. A variety of MyHC isoforms
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case of many skeletal muscle MyHCs, or by alternative
splicing or post-translational modification (e.g. [3,5,6]
and references therein). In vertebrate skeletal muscle, and
probably elsewhere, MyHC heterogeneity contributes to
the ability of cells to generate forces of different magni-
tude and kinetics. Slow skeletal muscle fibres contract
slowly because they contain slow MyHC isoforms that
hydrolyse ATP slowly. In contrast, fast fibres generate
greater forces and contain fast MyHCs which hydrolyse
ATP rapidly [7]. Skeletal muscle cells also contain so-
called non-muscle MyHCs, which may be involved in reg-
ulating muscle differentiation and muscle cell shape [8].
Thus, individual cells express several MyHCs with specific
functions, and similar cell types often contain distinct sets
of MyHCs that help confer differences in cell behaviour.
MyHCs show high amino acid sequence conservation
both between functionally-related isoforms within a spe-
cies and in homologous isoforms across species. Sequence
divergence occurs predominantly at a small number of
loci within MyHC that are presumed to confer particular
contractile or other properties upon the MyHC isoforms.
Evidence in favour of this view has come from the use of
antibodies to demonstrate that MyHCs of similar function
in skeletal muscles of organisms from fish to man contain
the same isoform-specific epitopes (see, for example,
[9,10]). In addition, antibodies exist that will apparently
detect all members of one MyHC II sub-class, but no oth-
ers. For example, antibody A4.1025 recognises an epitope
near the ATP-binding site of all sarcomeric MyHCs, but
the epitope is not found in smooth or non-muscle MyHCs
[6,11]. Again, antibody N3.36 recognizes most, if not all,
adult fast skeletal MyHCs by binding to a conserved N-ter-
minal epitope, but does not normally recognize any slow
skeletal MyHCs [11,12]. Consistent with the view that this
epitope conservation reflects conservation of function,
exchange of variable domains between MyHC isoforms
has demonstrated that particular regions of the MyHC
molecule are responsible for its contractile properties
[13]. Thus, even the variable domains of MyHC are fre-
quently conserved within sub-classes of myosins.
Skin is noted for its tensile strength combined with sup-
pleness, properties conferred by the extensive cytoskele-
ton and intercellular connections that maintain tissue
integrity. Epidermis contains many morphologically dis-
tinct cell types that are readily identifiable based upon
their position within the tissue. Rodent epidermis under-
goes a series of differentiative and morphogenetic events
during development and in the repeating hair cycle during
adult life. The initially simple epithelium of embryonic
epidermis becomes stratified before birth, leading to cell
heterogeneity between epidermal layers. There is also cell
diversity within a single layer. Epidermal stem cells have
specific locations in the basal layer [14]. Hair follicles are
induced perinatally through a mesenchymal-epithelial
interaction that instructs a particular region of the surface
epidermis to undergo changes in cell shape and gene
expression [15]. The epidermal surface undergoes an
involution to form a multi-layered hair follicle, best com-
pared in structure to an epidermal leek embedded in der-
mal soil. It is thought that sheets of hair precursor cells
move down in the outer layers of the follicle away from
stem cells located at the 'bulge' region [16,17], and then
turn inward and move up the centre of the follicle, differ-
entiating as they go, to form the hair proper and its sup-
porting inner root sheath. Thus, a complex series of
proliferative, differentiative and morphological changes
are co-ordinated during epidermal development.
Here we report the discovery of a number of molecules
with MyHC epitopes that are found in a variety of epithe-
lial tissues and mark distinct cell types. These proteins
have the unusual feature of sharing structural similarities
with distinct isoforms of fast or slow sarcomeric muscle
MyHC, yet they associate with intermediate filaments. We
suggest that the several proteins with structural similarity
to MyHC isoforms could form links between the actin and
intermediate filament cytoskeletons.
Results
Embryonic day 18 (E18) rat epidermis contains antigens
for a number of antibodies previously thought to be spe-
cific for particular sarcomeric MyHC isoforms (Fig. 1, see
also Table 1 for a summary of antibodies, their known sar-
comeric MyHC epitopes and their reactivity with non-
muscle tissue). Among a set of eight monoclonal antibod-
ies raised against purifed human skeletal muscle myosin
[6,12,18] we found that A4.840, N3.36 and N2.261
detected subsets of cells in E18 epidermis. The A4.840-
antigen could be detected in all layers of epidermal cells
in cryosections of E18 rat skin (Fig. 1A). In contrast,
N3.36-antigen was present only within a subset of cells in
the basal layer (Fig. 1B). A third anti-skeletal muscle
MyHC antibody, N2.261 also weakly detected cells in
basal epidermis (Fig. 1C). At this stage of development,
A4.74- and A4.951-antigens were barely detectable (Fig.
1D,1E). Control IgM- and IgG-class anti-sarcomeric
MyHC antibodies A4.1519 and F1.652 showed no reac-
tion to epidermis, indicating that binding of A4.840,
N3.36 and N2.261 was specific (Fig. 1F,1G, respectively).
Skin antigens are not identical to skeletal muscle MyHCs
because monoclonal antibodies A4.1025 and MF20 did
not react with epidermis (Fig. 1H and data not shown),
even though each is reported to detect all isoforms of sar-
comeric MyHC [12]. Ten further mouse monoclonal anti-
bodies against sarcomeric MyHC isoforms did not react
with rat epidermis at any age examined. In particular, BA-
D5, BA-F8 and NA8 antibodies, all of which detect slowPage 2 of 14
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to show any reactivity with epidermis (data not shown).
Considering that A4.840- and N3.36-epitopes are nor-
mally expressed on the products of different sarcomeric
MyHC genes, the data above show that epidermis con-
tains molecules antigenically-related to, but distinct from,
sarcomeric MyHC. Hereafter we refer to these molecules
as 'MyHC-like' simply to denote this antigenic similarity.
To determine when and in which cells the MyHC-like
molecules are expressed, we analysed cryosections
throughout postnatal epidermal development when the
skin thickens and matures and hair follicles are formed,
and found additional sarcomeric MyHC antibody cross-
reactivities. By postnatal day 1 (P1) A4.840-antigen was
present in the full thickness of the suprabasal surface epi-
dermis and also within many cell layers of the hair follicle
(Fig. 2A, shown diagrammatically in 2F). N3.36-antigen
was restricted to a subset of basal cells in both surface epi-
dermis and an outer layer of the hair follicle (Fig. 2B). In
contrast to younger skin, in which hair follicles had not
yet begun to mature, we observed an A4.74-antigen in a
single layer of cells near the base of the growing hair folli-
cles (Fig. 2C). By P1, N2.261-antigen detected all basal
layer cells in surface epidermis, both those that express
N3.36-antigen and those that do not (Fig. 2D). However,
N2.261-antigen was not detected in the hair follicle (Fig.
2D). The N1.551-antigen was found restricted to a small
cluster of cells in the neck of hair follicles (Fig. 2E). Many
other anti-MyHC antibodies, such as A4.1025, F1.652 and
A4.1519, do not show any reactivity with skin (data not
shown). So, the patterns of expression of the MyHC-like
molecules change with development in ways that suggest
each may have specific functions in particular epidermal
cell types.
We examined the epidermis of species other than rat, on
the rationale that evolutionarily conserved epitopes are
likely to have functional significance. A4.840, N3.36 and
N2.261 showed similar staining in P5 rat back and adult
human scalp epidermis (Fig. 3). A4.840 detected most
cells in epidermis, although more weakly as the skin
cornified, and in the hair follicle (Fig. 3A,3D). In contrast,
N3.36 detected a few cells of the basal layer of P5 rat epi-
dermis, but not adult human surface epidermis. However,
the outer layers of the hair follicle were labelled in both
species (Fig. 3B,3F). As in rat, in human tissue A4.74 only
reacted with cells in the inner root sheath of hair follicles,
and N2.261 reacted with basal cells (compare Fig. 2D and
3C,3E,3G). In mouse skin, A4.840 and A4.74 reacted with
similar, if not identical, sets of cells to those detected in
the rat (Fig. 3H,3J). However, N3.36 did not detect pro-
teins in mouse skin (Fig. 3I). This again suggests that the
molecules in skin are not the same as those in muscles,
because N3.36 reacts to mouse sarcomeric MyHC, just as
Distinct MyHC-like proteins are expressed in different sub-sets of embryonic rat epidermal cellsFigure 1
Distinct MyHC-like proteins are expressed in different sub-
sets of embryonic rat epidermal cells. Transverse cryosec-
tions of E18 rat lower hindlimbs were allowed to react with 
monoclonal antibodies raised against human skeletal muscle 
myosin and detected by immunohistochemistry. A. Antibody 
A4.840, which detects slow MyHC isoforms in developing 
skeletal muscle, reacts throughout the epidermis. B. Anti-
body N3.36, which detects several neonatal and adult fast 
MyHC isoforms in skeletal muscle, also detects antigen(s) in 
the basal cell layer of the epidermis. C. Antibody N2.261, 
which detects epitopes present on both neonatal slow and 
adult fast IIa skeletal muscle MyHC, reacts weakly in the basal 
cell layer of skin, but not in muscle at this age. D. Antibody 
A4.74, which detects adult fast IIa MyHC in muscle, is not 
reactive at this age in muscle or epidermis. E. Antibody 
A4.951, which detects adult slow skeletal MyHC and is 
therefore not expressed in muscle at this stage, is very 
weakly-reactive in basal epidermal cells. F. Antibody 
A4.1519, which detects MyHC(s) that are expressed in all 
fetal rat myotubes, does not detect epidermis. G. Antibody 
F1.652, that reacts with rat embryonic skeletal MyHC, is not 
reactive with embryonic epidermis. H. Antibody A4.1025, 
that detects all sarcomeric MyHCs, does not react with epi-
dermis (arrow). All panels same scale. Muscle is visible in 
panels A, E-H and fibres are approximately 20 µm in 
diameter.Page 3 of 14
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ity in chicken skin and feather germs (data not shown).
Taken together, these data suggest a family of MyHC-
related molecules with substantial evolutionary conserva-
tion are expressed in epidermis.
The MyHC-like proteins are also expressed in other 
epithelial tissues
To shed light on the potential functions of the MyHC-like
molecules in epidermis, we analysed a variety of epithelial
and non-epithelial tissues for the presence of the MyHC-
like molecules. We never observed any reaction with any
non-epithelial tissues other than skeletal or cardiac mus-
cle, consistent with the fact that the monoclonal antibod-
ies to specific skeletal muscle isoforms were originally
screened for lack of reaction with several non-muscle tis-
sues [19]. However, we did find reactivity with several epi-
thelial tissues. A4.840 reacted broadly with all cells of the
gut epithelium, whereas N3.36 reacted in a small cluster
of cells at the base of each crypt (Fig. 3K,3L). A4.74-anti-
gen was undetectable in gut (Fig. 3M). N3.36 reacted with
the simple epithelium of the bladder (data not shown).
N3.36, N2.261 and A4.840 each reacted with distinct cell
populations in the non-neural retina (data not shown).
None of these tissues reacted with the general anti-sarco-
meric MyHC antibody A4.1025 (data not shown). Thus,
the new antigens may perform similar functions in several
epithelial cell populations.
Sub-cellular localisation of the MyHC-like molecules
Myosin IIs are generally cytoplasmic proteins that can
form filaments and generate force in concert with actin.
To determine whether the antigens we detected might
have a similar role, we examined the sub-cellular location
of each antigen. Initial analyses of cryosections using
immunohistochemistry and fluorescence showed that
A4.840-reactive molecules were at the cell periphery,
whereas A4.74- and N3.36-reactive molecules seemed to
accumulate more widely within the cytoplasm (Figs. 2,3).
To obtain better spatial resolution of molecules within
epidermal cells, we developed a method of partial
trypsinisation which loosened the connections between
cells while retaining their relative positions within the tis-
sue. Cryosections of this trypsinised material gave good
spatial resolution and clearly revealed that A4.840-reactiv-
ity was located at the plasma membrane in a punctate
distribution (Figs. 4A,4C). The punctate distribution of
A4.840-reactive material close to the plasma membrane
was highly reminiscent of the abundant desmosomes of
epidermis [20,21]. We employed anti-desmoplakin anti-
bodies in dual immunofluorescence confocal microscopy
to examine the possibility of co-localization more closely
(Fig. 4E,4F). Using fresh frozen cryosections which had
not been subjected to trypsinisation, we confirmed the
punctate distribution of A4.840-antigen and found it to
be strongly associated with desmoplakin immunoreactiv-
ity at cell borders (Fig. 4E). We compared images of
Table 1: Summary of antibodies, their known MyHC epitopes and epithelial reactivity.
Antibody Muscle reactivity Epithelial reactivity




Hair¶follicle Gut Non-neural 
retina
Bladder
A4.840 Slow/β Rod Embryo onwards All IRS/ ORS All + +
HRMC§ H HRMC HRMC HRMC* R R R
N3.36 Neo/adult fast N-terminal 25 aa Fetal/ postnatal Some basal cells ORS Crypt base + +
HRM H HRM HR (not M) HR (not M) R R R
N2.261 Slow/β + Fast IIA N-terminal 25 aa Neonatal 
onwards
Basal - - + +
HRM H(β) RM HR HR R R R
A4.74 Fast IIA Unknown Postnatal 
onwards
- IRS - - -
HRM RM HRM HRM R R R
N1.551 Neonatal + Adult 
Fast
Unknown Fetal onwards - Bulge? neck cell 
cluster
-
HRM HRM R R R
A4.951 Adult slow/β N-terminal 25 aa Postnatal 
onwards
Weak in fetus 
only
Bulge? neck cell 
cluster
-
HRM H RM R R R
A4.1025 All known 20 kd / 25 kd 
junction/ ATP site
Embryo onwards - - - - -
HRMCDZX H HRMCDZX HRM HRM R R R
Note that three antibodies (N3.36, N2.261 and A4.951) that detect MyHC-like antigens in epithelia have MyHC epitopes in the N terminus of the 
S1 fragment of the head. X-ray crystallography does not reveal a coiled coil (or any other conserved structure) in this region. §Letters under each 
entry indicate the species in which reactivity is observed: H human, R rat, M mouse, C chick, D Drosophila, Z zebrafish, X Xenopus. Absence of a 
species indicates data not available unless specifically noted otherwise. ¶IRS inner root sheath, ORS Outer root sheath, * in feather germ.Page 4 of 14
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plakin-labelling (Fig. 4F) and scored the number of
puncta of fluorescence that labelled with one, the other or
both antibodies. Greater than 90% of puncta showed co-
localization of A4.840-antigen and desmoplakin. We
obtained two pieces of evidence in favour of an intracellu-
lar location for the A4.840-antigen: a) A4.840 showed no
punctate staining in wholemount stains of unpermeabi-
lised P7 rat skin but readily labelled the surface of hair fol-
licle cells in punctate distribution in wholemount skin
fragments permeabilised with Triton X100 (Fig.
4G,4H,4I), b) punctate A4.840-reactivity could be
detected in permeabilized cultured skin cells (see Fig. 5A),
MyHC-like molecules are developmentally regulated in skinFigure 2
MyHC-like molecules are developmentally regulated in skin. 
Cryosections of P1 rat back skin was reacted with A4.840 
(A), N3.36 (B), A4.74 (C), N2.261 (D) or N1.551 (E) and the 
antibody detected by peroxidase immunohistochemistry. 
Hair follicles were sectioned longitudinally, as illustrated dia-
gramatically (F). A4.840 labelled all upper layer epidermal 
cells, whereas N3.36 labelled only some basal cells of the sur-
face epidermis and an outer layer of the hair bulb. A4.74 
labelled part of the root sheath at the base of the hair shaft. 
N2.261 detected the whole basal layer of surface epidermis, 
but not the hair follicle. N1.551 labelled only a small group of 
cells on one side of the neck of the hair bulb (arrow, E). Mus-
cle (mus) showed the expected MyHC immunoreactivity for 
this stage of development. Dermis (D), surface epidermis 
(SE), basal epidermis (BL), inner root sheath (IRS), outer root 
sheath (ORS) and dermal papilla (DP). All panels same scale. 
Muscle is visible in panel B and fibres are approximately 25 
µm in diameter.
The MyHC-like molecules are evolutionarily conserved and found in a vari ty f epithelial tissuesFigure 3
The MyHC-like molecules are evolutionarily conserved and 
found in a variety of epithelial tissues. Cryosections of P5 rat 
tail skin (A-C), adult human scalp skin (D-G), P3 mouse back 
skin (H-J) and adult rat jejunum (K-M) were reacted with 
A4.840 (A,D,H,K), N3.36 (B,F,I,L), N2.261 (E) or A4.74 
(C,G,J,M) and the antibodies detected by peroxidase-based 
immunohistochemistry. A4.840-antigen is found in all tissues 
(arrows, A,D,H,K), but is most readily detected in lower 
suprabasal layers as skin cornifies in the older tissue (arrow, 
A). N2.261-reactivity was observed in the basal layer of 
human skin (arrow, E). N3.36-antigen is present in a subset 
of cells in a single layer in human and rat epidermis (arrows 
B,F), although neither the dl DBA mice shown nor two other 
wild type strains (Balb/c, SwissWebster) showed any reaction 
(I). A4.74-reactivity was found in the inner root sheath of 
human, rat and mouse hair follicles (arrows, C,G,J). Note 
that the pigmented hair shaft also appears dark (asterisks, D-
J). Dermal muscle provided positive controls for antibody 
reactivity (arrowheads, H,I). In the gut, A4.840-antigen was 
present on most surface epithelial cells of both crypt and vil-
lus (arrows, K). N3.36 detected an antigen in cells at the base 
of crypts, similar to Paneth cells in location (arrow L). se, 
surface epidermis; m, muscle; d, dermis; c, crypt region; v, vil-
lus region; sm, smooth muscle. All panels same scale. Muscle 
is visible in panels H-J and fibres are approximately 30 µm in 
diameter.Page 5 of 14
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Cellular and sub-cellular localisation of A4.840-antigen. 
Immunofluorescent detection of A4.840 (A,C,E,F red; G,I 
green), A4.74 (B,D, green), and desmoplakin (E,F, green; H,J, 
red) in rat epidermis. A-D. A4.840-epitope is distributed at 
the cell periphery of most cells of trypsinised epidermis (A,B 
a hair follicle bulb in high mag transverse section; C,D surface 
and hair follicle epidermis in low mag longitudinal section). 
The A4.74-epitope is in fibrillar structures within the outer-
most layer of A4.840-reactive cells in the root sheath 
(arrows, B,D). E,F. Confocal microscopy using A4.840 (red) 
and anti-desmoplakin (green) on cryosections of P7 rat back 
skin. Desmoplakin co-localises with A4.840-antigen labelling 
at the surface of cells in many layers of the root sheath of the 
hair follicle (E). At higher magnification, desmoplakin and 
A4.840-antigen co-localise in a punctate array at cell borders 
in surface epidermis (F). G-J. Intact pieces of P7 rat epider-
mis were stained for A4.840 (green G,I) and desmoplakin 
(red H,J). A network of cell surface staining is detected with 
both antigens after permeabilisation with 1% Triton X100 
(G,H arrows), but not without such permeabilisation, when 
only background fluorescence was detected (I,J arrows).
Distribution of MyHC-like antigens is retained in epidermal cells n tissue culture and mim cked in cardiomyocytesFigure 5
Distribution of MyHC-like antigens is retained in epidermal 
cells in tissue culture and mimicked in cardiomyocytes. Pri-
mary dissociates of P1 rat skin (A-D) were grown in culture 
and stained for A4.840 (A) or N3.36 (C) and A4.74 (B,D) by 
dual immunofluorescence. After two days in culture, fibrillar 
A4.74-reactive material is visible in large spindle-shaped cells, 
some of which did not contain A4.840-reactive material 
(arrows, A,B). Other A4.74-reactive cells do contain A4.840-
antigen (insets A,B). Large 'donut' cells contain abundant 
A4.840-reactive dots near the cell surface (arrowhead, A). 
These donut cells are probably from the prickle cell layer of 
the surface epidermis based on a) the appearance of cells of 
similar morphology in the prickle cell layer of cryosections of 
near-dissociated trypsinised skin and b) the presence of these 
cells in dissociated 'epidermal' layer cultures, but not in 'der-
mal' layer cultures that contain numerous dermis and hair 
follicle cells but little surface epidermis (data not shown). 
After one day in culture, N3.36-labelled material is also fibril-
lar (arrow, C) but is co-expressed in A4.74-reactive cells 
extremely rarely (C,D). Confocal microscopy of primary cul-
tures of neonatal rat cardiomyocytes (E-O) revealed staining 
for A4.840 (E,H,K,L,O), plakoglobin (F), pan-cadherin (J,N), 
desmoplakin (G), myomesin (I,K) and desmin (M,O) by triple 
immunofluorescence. Significantly enhanced A4.840-antigen 
is detected at the junctions between cells that are marked by 
plakoglobin and desmoplakin (E-G). Cytoplasmic A4.840-
reactivity is also present in some cells, and co-localises in M-
lines detected by myomesin (H-J, shown in higher magnifica-
tion in K,O). Other cells containing sarcomeric striations do 
not contain detectable A4.840-antigen (asterisks, H-J). The 
A4.840-antigen is not localised in the Z line marked by 
desmin (L-O). Bars = 2 µm in K,O, 10 µm in rest.Page 6 of 14
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ation or permeabilization (data not shown). Attempts to
immunolocalise the A4.840-antigen by electron micros-
copy have so far been unsuccessful, probably due to fixa-
tion sensitivity of the A4.840 epitope (unpublished
observations kindly provided by Alison North and David
Garrod). We conclude that A4.840-antigen is co-localized
with desmosomes.
Desmosomes are not only present in epithelia but also in
other tissues under tensile stress. For example, in the myo-
cardium, desmosomes are found at specialised cell-cell
contacts, the intercalated disks, where cardiomyocytes are
tightly connected to ensure mechanical coupling during
the contraction process. Primary cultures of cardiomyo-
cytes continue to beat and intercalated disk-like structures
are re-established. The A4.840 antigen co-localized with
desmoplakin, plakoglobin and pan-cadherin antigens at
these intercalated disk-like structures (Figure
5E,5F,5G,5H,5J,5L,5N). Additional A4.840 reactivity was
found in the myofibrils (Figure 5H,5I,5J,5K), localized in
the region of the M-band of the sarcomere, as demon-
strated by double-labelling with antibodies to myomesin,
an integral component of the M-band that is responsible
for integrating myosin and titin filaments in the sarcom-
ere [22]. However, only some cardiomyocytes showed
these sarcomeric striations with the A4.840 antibody and
there are myomesin-stained M-bands that do not show
the A4.840 signal (asterisk in H-J). Double staining of the
A4.840 antigen with the muscle intermediate filament
protein desmin, which is localized around the Z-disks of
the sarcomere, revealed alternating striations of the myofi-
brils (Figure 5L,5M,5N,5O). Taken together, these data
raise the possibility that in cardiac muscle, in addition to
A4.840-reactive slow sarcomeric MyHC, the novel A4.840
antigen is also expressed and associated mainly with the
intercalated disk.
Unlike the A4.840-antigen, A4.74-reactivity was distrib-
uted in cells of the hair follicle in a fibrillar arrangement
(Fig. 4B,4D). Dual stained sections showed that A4.74-
epitope was present in the outermost layer of the A4.840-
epitope-containing cells of the hair follicle just above the
bulb (Fig. 4A,4B). Similar comparisons between N3.36-
and A4.74-antigens showed each to be present within a
distinct concentric layer of cells in the follicle, with N3.36
reacting with cells further from the hair itself (Fig. 6A).
Both antigens were cytoplasmic (Fig. 4B,4D and Fig. 6).
No extracellular or nuclear labelling was detected with
any of the three antibodies. Thus, the MyHC-like mole-
cules are distributed distinctly within cells.
The A4.74- and N3.36-antigens were localized in fibrillar
structures within the cytoplasm of fibres (Fig. 4B,4D and
Fig. 6C,6D). To characterize their distribution in more
detail we tested whether these fibrillar structures repre-
sented one of the described cytoskeletal fibrillar systems.
Neither N3.36- nor A4.74-reactive material was co-local-
ized with actin filaments labelled with rhodaminated-
phalloidin (Fig. 6D,6E and data not shown). On the other
hand, A4.74-antigen localized to filaments within the
Association of the MyHC-like molecules with intermediate filament-containing structuresFigure 6
Association of the MyHC-like molecules with intermediate 
filament-containing structures. N3.36-antigen (A,B,F red; D 
green), A4.74-antigen (A-C, green; G, red), A4.840-antigen 
(C, red), phalloidin (E), pan-keratin (F, green) and keratin 5 
(G, green) in cryosections of rat epidermis. Longitudinal sec-
tion of hair follicle from partially-trypsinised P7 rat skin 
showing the single layer of N3.36-labelled cells of the hair 
bulb (A, red), immediately external to the A4.74-labelled 
layer (A, green). At higher magnification, the same distribu-
tion is observed in confocal cryosection of an intact rat hair 
follicle with A4.74-antigen present in the layer internal to the 
N3.36-antigen (B). A4.74-labelled fibrils (C, green) appear to 
course through the cytoplasm of cells of the root sheath link-
ing to regions of A4.840-labelled plasma membranes (C, red). 
Dual localisation of N3.36-reactive fibrils by immunofluores-
cence (D) and actin microfibrils with rhodaminated-phalloidin 
(E) show that the major location of the MyHC-like molecule 
is not on actin cytoskeleton. Similar results were obtained 
with A4.74 and phalloidin. The N3.36-antigen (red, F) is asso-
ciated with the outermost layer of keratin-containing cells 
(green, F). These cells also contain keratin 5 (green, G), 
based on their position immediately external to the A4.74-
reactive cell layer (red, G).Page 7 of 14
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nect desmosomes, revealed by abundant A4.840-antigen
(Fig. 6C). As desmosomes are connected in this manner
by keratin filaments in epidermis [23], this finding sug-
gested that A4.74-antigen may be keratin intermediate fil-
ament-associated. The sub-cellular distribution of N3.36-
antigen was very similar to that revealed by an anti-pan-
keratin antibody in the outermost layer of the root sheath
(Fig. 6F), although not all keratin-reactive material co-
localized with N3.36-antigen within these cells. Based on
dual staining for A4.74-antigen and keratin 5, it appears
that N3.36-antigen is expressed in a subset of cells that
express keratin 5 (Fig. 6G). Taken together, these data sug-
gest that both the A4.74-antigen and N3.36-antigen are
co-localized with intermediate filament proteins in the
hair follicle.
To analyse antigen location in more detail, we examined
primary dissociated cells from P1 rat skin that had been
grown in culture for two days. A4.840-antigen was often,
but not exclusively, localized in plasma membrane-asso-
ciated dots in the cultured cells (Fig. 5A). Both the A4.74-
and N3.36-antigens remained in fibrillar structures within
distinct populations of these dissociated and fixed cul-
tured epidermal cells (Fig. 5B,5C,5D). Whereas A4.74-
antigen was in filaments in either large oval or small
round cells in these primary dissociates, most A4.840-
antigen that we could detect was located in large cells with
a morphology reminiscent of cells in the prickle cell layer
of our partially trypisinised tissue (Fig. 5A,5B). In con-
trast, N3.36-antigen was in a distinct population of cul-
tured cells not labelled with A4.74 (Fig. 5C,5D), just as we
observe in vivo. The numbers of cells expressing the
MyHC-like antigens appeared to decline with time in
dissociated cell culture, suggesting the loss of tissue integ-
rity or cell-cell contact may lead to loss of the antigens.
However, due to the small numbers of antigenically-reac-
tive cells, we could not eliminate the possibility of cell
death accounting for this observation (data not shown).
Consistent with the idea of loss of MyHC-like antigens in
culture, after two days in vitro we observed A4.74-reactive
cells that did not contain A4.840-antigen (Fig. 5A,5B).
Such cells were never observed in vivo. Examination of
differentiating human epidermal keratinocyte cultures
also failed to reveal any of the MyHC-like antigens, even
though differentiation-marker keratins were expressed
and desmosomes were formed (data not shown). These
results suggest that expression or accumulation of the
MyHC-like antigens, requires some aspect of the in vivo
environment that is not mimicked in the culture systems
examined.
Molecular characterisation of A4.74-antigen
To gain further insight into the nature of the MyHC-like
antigens, we performed a partial purification. Western
analysis of P9 rat tail skin homogenates revealed a protein
of around Mr 230000 that could be detected by antibody
A4.74 (Fig. 7A). Antibodies A4.840 and N3.36 did not
detect any protein in skin homogenates, despite detecting
slow and fast MyHCs (respectively) from muscle tissue,
and so could not be analysed further (data not shown).
However, the lack of reactivity of these antibodies on skin
Western blots supports the notion that the skin and mus-
cle antigens are distinct. The detected skin A4.74-antigen
was not a conventional skeletal muscle MyHC because it
migrated more slowly than muscle MyHCs and it did not
react with antibodies, such as A4.1025, that detect all iso-
forms of skeletal muscle MyHC (Fig. 7A). Although no
obvious band was visible on Coomassie Blue-stained gels
at the position of the A4.74-antigen, the antibody reacted
strongly with this Mr 230 000 band, even in comparison
to its reactivity with muscle MyHC (Fig. 7B). Moreover,
the skin sample did not contain skeletal muscle, as anti-
body A4.1025 does not detect any protein in tail skin,
although it readily detects MyHC in skeletal muscle (Fig.
7A). A4.1025 does detect MyHC in proteins isolated from
P7 rat back or head skin because these tissues are usually
contaminated during isolation with the underlying thin
dermal muscle layer, the paniculus carnosus, which is not
present in the tail (data not shown and Fig. 3). Other
antibodies that detect either all skeletal MyHCs or subsets
of these proteins do not react with the skin sample. For
example, F1.652, an antibody which recognizes embry-
onic mammalian MyHC, does not detect proteins in rat
skin (Fig. 7A). Thus, skin contains a skeletal muscle fast
IIA MyHC-related protein that is not identical to the mus-
cle myosin.
We obtained further evidence that the A4.74-antigen in
skin was not skeletal muscle fast IIA MyHC. When skeletal
muscle is homogenised in high salt solutions myosin is
readily extracted. Similar homogenisation of skin failed to
release the A4.74-antigen (data not shown). Indeed,
homogenisation by mechanical, manual or sonication
procedures in solutions containing high salt with or
without various detergents failed to release the A4.74-
antigen from material that could be pelleted by centrifu-
gation at 100,000 × g for 15 minutes. In contrast, solubi-
lisation of tissue in buffer containing 6 M urea did release
the A4.74-antigen to the high speed supernatant (Fig. 7C).
Subsequent dialysis against PBS caused a re-precipitation
of various highly insoluble skin proteins, including kerat-
ins, and this procedure also quantitatively precipitated the
A4.74-antigen (Fig. 7C). Dialysis into 0.6 M KCl-contain-
ing buffer, which would retain sarcomeric myosin in the
supernatant, did not affect the precipitation of the A4.74-
reactive protein in skin (data not shown). Therefore, the
A4.74-reactive 230 kDa protein in skin co-purifies with
skin keratins, and is not skeletal fast IIA MyHC.Page 8 of 14
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Skin A4.74-antigen is distinct from fast skeletal myosin IIA and co-purifies with keratin. A. Western analysis of P9 rat tail skin 
proteins (Sk) shows that proteins around Mr 230000 are detected by A4.74, but not by F1.652 or A4.1025. A4.74 detects a 
protein of Mr 220000 typical of skeletal muscle MyHC fast IIA in samples of P29 rat extensor digitorum longus (edl) muscle 
(Mu) but no proteins in P7 liver (Li). A similar Mr 220000 band was detected with anti-embryonic skeletal myosin antibody 
F1.652 in neonatal P7 lower hindlimb muscle (Mun) and with the general anti-sarcomeric myosin antibody A4.1025 in P35 
lower hindlimb muscle (Mua). The faint Mr~45 000 band (arrowhead) in the skin sample is a non-specific cross-reaction, as the 
control secondary antibody alone detects this band (2°). Comparable total protein (~50 µg) was loaded per lane and checked 
by Coomassie stain of a duplicate gel. B. The A4.74-antigen in skin (Sk) was more readily detected than fast IIA MyHC in P29 
edl (Mu) muscle in Western blots, even when more muscle protein was loaded as indicated with Coomassie blue staining in 
identical lanes. C. When skin is dissociated in 6 M urea, the A4.74-reactive proteins (upper panel) are fully dissolved and iso-
lated quantitatively in a high speed supernatant (prd) which contains a wide range of proteins including abundant keratins 
(bands below Mr 66000, lower panel, Coomassie blue stain of a replicate gel). In this experiment, absolute loaded protein was 
not determined but a precisely similar proportion of the total sample was run in each lane, as can be seen from the Coomassie 
stain. After dialysis into PBS to remove urea, no protein or antigenic reactivity is lost (pd). Upon re-centrifugation, all detecta-
ble A4.74-reactive protein is found in the pellet (p) associated with keratins, whereas many other proteins remain in the super-
natant (s/n). Control antibody F1.652 demonstrates the non-specificity of the low Mr band (arrowhead), but shows no 
reactivity to A4.74-antigen, whereas A4.74 detects the Mr 220000 skeletal IIA fast MyHC in P29 edl muscle extract (Mu). Each 
skin lane contains an equivalent proportion of the original sample.Page 9 of 14
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We have found several molecules which, although anti-
genically-related to sarcomeric MyHCs, are distinct from
them. These evolutionarily conserved molecules have dis-
tinct cellular and sub-cellular distributions within epithe-
lial tissues that indicate their involvement in cytoskeletal
organisation and/or dynamics.
Molecular nature of the MyHC-like proteins
The single MyHC-like molecule in skin of which we have
been able to determine the size had an apparent Mr
around 230 000, the size range of non-muscle myosin IIs.
This, together with its sub-cellular location and affinity for
keratin shows that the protein is not sarcomeric fast IIA
MyHC. The co-incidence of size and antigenicity argues
against a chance cross-reactivity of A4.74 to an otherwise
unrelated protein in skin. Although various described pro-
teins share some characteristics with the A4.74-antigen,
we have been unable to find proteins in the literature
whose characteristics and expression patterns match with
any of the newly-described molecules. For example, both
the A4.74-antigen and each of the other MyHC-like mol-
ecules in epidermis, show different non-overlapping cel-
lular distributions from that of any of seven keratin
antibodies tested (against keratins 1,5,6,10,14,16 and
pan-keratin; unpublished results). Similarly, although
synemin, paranemin and BPAG1 are ~Mr 230 000 pro-
teins associated with intermediate filaments, they do not
have the same cellular distribution as any of the novel
MyHC-like antigens [24,25]. Moreover, the presence of
five distinct sarcomeric MyHC epitopes in different skin
cells raises the possibility that the A4.74-antigen in skin
constitutes one member of a family of MyHC-like pro-
teins performing subtly different functions in distinct skin
cell populations.
Particular anti-MyHC antibodies that react with skin
detect primary amino acid sequence epitopes spread
throughout the length of sarcomeric myosin IIs (see Table
1). For example, A4.840 recognizes slow β/cardiac MyHC
rod polypeptides expressed in transfected bacteria or COS
cells [6,18]. On the other hand, the N2.261 epitope is
located at the N-terminal end of the head of slow β/car-
diac MyHC, and may depend on post-translational modi-
fications [6]. N3.36 detects the N-terminus of many fast
MyHCs and can also be detected on COS cell-expressed
sarcomeric perinatal MyHC [6,11,12]. The location of the
A4.74 epitope on fast IIA sarcomeric MyHC is unknown.
In our view, therefore, it is likely that the evolutionarily
conserved epitopes on the new proteins have some ele-
ment of common function with the evolutionarily con-
served epitopes on distinct isoforms of skeletal muscle
MyHC. As three of the skin-reactive antibodies detect
epitopes in the N-terminus of the sarcomeric MyHC S1
head region, it is highly unlikely that these cross-reactions
represent chance similarity of a coiled-coil structure.
A4.840 and A4.74, however, may detect coiled coil
epitopes which might contribute to their co-localization
with intermediate filament that are rich in such structure.
Nevertheless, evolutionary conservation argues that these
epitopes structures are not chance cross-reactivities. We
envisage three possible mechanisms by which such dupli-
cation of epitopes could arise. First, the skin molecules
could be derived from the same genes that encode skeletal
muscle MyHC isoforms. This is unlikely, as such a model
would require extensive alternative splicing of the RNA
transcripts of several MyHC genes because no single skel-
etal muscle MyHC gene encodes all the epitopes
[6,12,18]. Splicing would be required a) to remove the
many conserved skeletal muscle MyHC epitopes which we
do not detect in the skin proteins and b) to replace them
with sufficient material to maintain the apparent Mr of the
protein above 220 000, at least in the case of the A4.74-
antigen. Second, there could be a parallel MyHC gene
family formed by duplication of several muscle MyHC
genes followed by retention of many of the epitopes due
to functional demands on the new gene family. Such a
model might suggest that the distinct MyHC-like proteins
in skin cells could generate distinct forces or develop force
at different rates or in response to different activators.
Again this is unlikely as the complete murine genome
sequence contains no obvious candidate gene set. Third,
there could have been extensive convergent evolution of
some other family of myosin or non-myosin proteins to
allow each to contain one of these MyHC-like epitopes –
presumably either due to interaction with as yet unknown
partner proteins or to some other conserved function.
One possibility is that the new proteins contain MyHC-
like epitopes to control structural changes within the mol-
ecule that relate to their mechanical properties.
Sub-cellular location of the MyHC-like proteins and their 
putative function
All three MyHC-like molecules examined in detail are co-
localize with cytoskeletal structures. The A4.74-antigen
co-purifies with keratin intermediate filament proteins
and co-localises to intermediate filaments in skin tissue,
and in cultured epidermal cells. The N3.36-antigen also
localises to filamentous structures in the basal layer cells
of epidermis. Similarly, the A4.840-antigen is present at
desmosomes in a variety of cell types, and is also found in
the intercalated discs of cardiomyocytes. Desmosomes are
the target plasma membrane anchorage site for keratin
filaments in epithelial tissues [23], including epidermis
and gut, so A4.840-antigen in skin cells is co-localised
with the ends of the intermediate filaments in this tissue.
This location for the MyHC-like antigens suggests that the
function of these proteins may be concerned with the
structure and/or dynamics of the intermediate filament
network.Page 10 of 14
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MyHC head (N3.36, N2.261 and possibly A4.74) on the
new molecules raises the possibility that the molecules
may function either as molecular motors or as actin bind-
ing proteins. It also makes the idea that these antibodies
cross-react to intermediate filaments due to the chance
recurrence of epitopes in coiled-coil protein structure, as
found in the rod regions of MyHC, unlikely to be correct.
A number of proteins that cross-link microtubules to
microfilaments have been described (see, for example,
[26–28]), but fewer are known to cross-link intermediate
filament cytoskeleton and microfilaments [25,29–31].
The MyHC-like proteins are new candidates for such
cross-links in epithelia. It is striking that in cardiac muscle
the A4.840 antibody reacts at the intercalated disks, where
myofibrils are anchored in adherens-type junctions, in
close proximity to desmosomes that contain the cardiac
intermediate filament protein desmin. Since the interca-
lated disks are the sites of mechanical coupling between
cardiomyocytes, specialised cross-links might be required
there to ensure proper function. Plectin, a cytoskeletal
protein that crosslinks intermediate filaments with micro-
filaments and microtubules is also concentrated at inter-
calated disks [32] and its absence leads to partial
disintegration of intercalated disk structure at the
ultrastructural level [33]. Our results suggest that the
A4.840 antigen also acts as an additional cross-linker in
the intercalated disks in order to cope with the immense
mechanical stress at this site.
On the other hand, structural features of MyHC unrelated
to its actin binding capacity could also be conserved in
evolution. We have suggested that some of the isoform-
specific epitopes on sarcomeric MyHCs may regulate pro-
tein stability and/or turnover [6]. These N-terminal
epitopes (N3.36, N2.261 and A4.951 (which last detects
similar skin cells to N1.551, unpublished result)) are also
found in the new skin molecules. The need to turn over
sarcomeric MyHCs while maintaining an intact sarcom-
eric framework is a characteristic that is shared with stable
cytoskeletal structures like desmosomal intermediate fila-
ments, but not with most non-muscle MyHCs. Resolution
of these issues will await the sequencing of the skin
molecules.
Cellular location of the MyHC-like molecules defines 
epidermal cell sub-populations
Regardless of the nature and function of the MyHC-like
molecules, they appear to define populations of epider-
mal cells. Moreover, analysis of the expression of each
antigen, reveals common themes in the cell types in which
they are expressed. In epidermis, the N3.36-antigen is
located within cells of the basal layer, which contains
both the slowly-replicating stem cells, and the highly pro-
liferative precursors of the upper layers of the skin
(reviewed in [14]). Early in development, almost all basal
layer cells are labelled by N3.36, as is the entire simple
epithelium of the bladder. But later, as the N2.261-anti-
gen is up-regulated in the basal layer, the N3.36-antigen
becomes restricted to a sub-population of basal cells as
the skin matures. This sub-population, nevertheless,
appears too abundant to be the slowly-dividing stem cells
[34]. As cells leave the basal layer and begin to differenti-
ate, N2.261-antigen is lost and A4.840-antigen is up-regu-
lated. These cells do not express N3.36. Thus, in surface
epidermis there is a defined developmental progression of
three of the MyHC-like antigens.
In the gut epithelium, the location of the N3.36-antigen
in the cells at the base of crypts is also suggestive of label-
ling of cells that are recently derived from, yet are one step
more differentiated than, the stem cells [35]. The A4.840-
antigen is expressed the vast majority of cells of the rest of
the gut epithelium, suggesting a progression from stem
cell, to N3.36-reactive cell and then A4.840-reactive cell.
In both epidermis and gut, the N3.36- and A4.840-reac-
tive cell populations have distinct location and geometry.
In the specialised epidermis of hair follicles, a similar, but
more complex, sequence of expression is observed. As
epidermal buds begin to invaginate, regions lacking
N3.36- and N2.261-antigens, but expressing A4.840-anti-
gen, appear. N2.261-antigen was not subsequently
detected in follicles. However, N3.36-antigen re-appeared
in the outermost layer of the maturing follicle. This sug-
gests location in proliferative early precursors of the folli-
cle that are thought to be recently-derived from stem cells
in the bulge region [16], and give rise to the inner layers
of the follicle, including the hair [17]. A4.840-antigen
showed a complementary pattern, as in surface epidermis,
with expression extending throughout the follicle from
the surface epidermis, except for the outermost layer of
cells that contain keratin 5 and the N3.36-antigen. The
N1.551-antigen detects a small group of cells in a similar
vicinity to the bulge region described in human follicles,
which is the location of follicular stem cells [16]. If
N1.551-antigen were present within follicular stem cells,
its late appearance in rodent hair would suggest that this
cell type is only formed after the initiation of the first ana-
gen. The A4.74-antigen appears late and is only apparent
as follicular cells begin to generate the hair proper. This,
together with its location in inner root sheath cells, sug-
gests that the cells that express A4.74-antigen may be ter-
minally-differentiating cells destined to support the hair
in its outgrowth from the follicle. However, as the lineage
of various cell layers within the hair follicle has not been
precisely determined, we are unsure of the exact nature of
these cells. Nevertheless, it is clear that in the hair follicle
there is a characteristic progression of the new MyHC-like
antigens.Page 11 of 14
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mark distinct subsets of precursor cells of epithelial tis-
sues, whereas the A4.840-antigen is expressed in a wide
variety of more mature, although not necessarily termi-
nally-differentiated, epithelial and non-epithelial cell
types that require the tensile strength conferred by desmo-
somal junctions. In contrast to the widespread expression
of A4.840-antigen, the A4.74-antigen is so far observed
only in late-stage cells in the inner root sheath of the hair
follicle, a highly specialised cell subset. It is striking that
the order of expression of the new antigens is very similar
to the expression of the same epitopes on skeletal muscle
MyHC isoforms. The two most broadly expressed of the
new antigens react with A4.840 and N3.36, the two anti-
bodies that mark general slow and general fast sarcomeric
MyHCs, respectively, that are expressed early in develop-
ment and widely [6,12,18]. The N2.261-antigen is the
next most frequent, and also the next to appear develop-
mentally, in epidermis. Similarly, the N2.261 epitope
appears in slow muscle fibres after the A4.840 epitope and
is present on both slow and fast IIA sarcomeric MyHCs
[6,18]. And the last adult sarcomeric MyHC isoforms to
appear in rodent skeletal muscle are A4.951- and A4.74-
reactive adult slow and adult fast IIA MyHCs, respectively
[6,18]. This is paralleled by the late appearance of A4.74-
and A4.951-antigens in specific subsets of cells in the hair
follicle. Thus, the timing of developmental expression of
the new antigens supports the notion of some parallel
function(s) with sarcomeric MyHCs. Further understand-
ing of the antigens may shed light not only on epithelial
biology, but also the role of MyHC isoform transitions in
skeletal muscle.
Conclusions
The chief significance of this work is the identification of
a set of apparently novel intermediate-filament co-local-
ized proteins in epithelial tissues. The full nature and
sequence of the molecules remains unknown.
Nevertheless, our antibody reagents should permit further
identification or manipulation of these molecules.
Methods
Biological materials
Wistar rats were bred in the KCL animal facility, and dl
DBA mice obtained from Jackson Labs. Human skin
samples were generously provided by Niels Krejci and
Irene Leigh. Keratinocyte cultures were a gift from Fiona
Watt. Irene Leigh also kindly provided a range of anti-ker-
atin antibodies. All MyHC antibodies used in this study
can be purchased form Alexis, Switzerland.
Immunohistology
Small pieces of fresh postnatal day 1–6 (P1-6) rat back
skin were rapidly frozen and cryo-sectioned at 10–16 µm
onto gelatinized slides. Where indicated, fresh skin
fragments were incubated in 2% trypsin in PBS for 4 hours
at room temperature before freezing to loosen the skin
structure. All steps were performed in a humidified box at
room temperature. Sections were blocked with PBS, 5%
HS for 30 min. Slides were then incubated with A4.1025,
F1.652, A4.951, N2.261, A4.74, pan-keratin (IgG) and
A4.840, N3.36, A4.1519, N1.551, anti-keratin 5 (IgM)
monoclonal antibodies for 1 hr, washed for 1, 5, 15 min
in phosphate buffered saline (PBS) 0.5% Tween 20, and
IgM or IgG detected with either Texas red- or biotin-con-
jugated goat anti-mouse IgM (µ-specific)(Vector) or FITC-
or biotin-conjugated goat anti-mouse IgG (γ-spe-
cific)(Vector) diluted in PBS 5% HS, respectively. Slides
were washed three times in PBS 0.5% Tween 20 for a total
of 30 min and then mounted under coverslips in polyvi-
nylalcohol anti-fade, or reacted with the ABC kit (Vector)
and diaminobenzidene/H2O2. Immuno-labelling was
analysed using a Zeiss Axiophot fluorescence microscope.
For confocal microscopy, IgM was detected with biotin-
conjugated goat anti-mouse Ig (µ-specific), followed by
rhodamine-labelled streptavidin diluted in PBS, 5% HS.
Antigen purification
Muscle-free skin peeled from P6-9 rat tail was mechani-
cally homogenised on ice in PBS 0.2 mM EDTA contain-
ing protease inhibitors 1 mM PMSF and 1 µg/ml each
aprotinin, leupeptin and pepstatin A. Homogenate was
centrifuged at 1000 × g for 10 min and the supernatant
discarded. To solubilize skin proteins, pellet was re-sus-
pended in 6 M urea, PBS, 0.1% Tween, 0.2 mM EDTA, 2
mM dithiothreitol, protease inhibitors and incubated in a
water bath sonicator (Sonomatic, Langford Ultrasonics)
for 2 hrs at 4°C. To remove insoluble material the solu-
tion was centrifuged at 100,000 × g (Beckman TL-100) for
15 min. The solubilization buffer was removed by dialysis
of <1 ml sample against two changes of 800 ml PBS, 0.2
mM EDTA, 0.1 mM PMSF at 4°C for 4 hr. To separate pro-
teins soluble and insoluble in PBS after dialysis the mate-
rial was re-spun at 100,000 × g for 15 min.
Western Blotting
Crude muscle and liver extracts were prepared by hom-
genization in 10% SDS, 50 mM Tris/HCl pH 7.4, 5 mM
EDTA. After a brief spin to remove tissue, crude superna-
tant was used in Fig. 7A. Samples were diluted 1:1 with
SDS sample buffer (0.5 M Tris/HCl pH 6.8, 20% glycerol,
5% SDS, 10% β-mercaptoethanol), boiled for 2–5 min,
electrophoresed through standard 0.1% SDS, 7.5% poly-
acrylamide separation gel [36]. After electrophoresis some
gels were stained with Coomassie Brilliant Blue. For
immunoblotting, the electrophoresed proteins were
transferred in a semi-dry apparatus [37] to nitrocellulose
membranes (Hybond C-super, Amersham) for 75 min at
220 V. Membranes were stained with Ponceau red and
photocopied to record the position of major bands.Page 12 of 14
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overnight at 4°C. All other procedures were done at room
temperature. After brief rinsing in PBS, strips of mem-
brane were incubated with monoclonal antibodies
diluted 1:10 in PBS, 2% BSA, then rinsed for 1, 5, 15 min
in PBS and incubated with goat anti-mouse IgG (whole
molecule) peroxidase conjugate antibody (Sigma) diluted
1:100 in PBS, 2% BSA. Proteins detected by the antibodies
were visualized by incubation of the membranes with ECL
luminescent peroxidase substrate (Amersham) for 1 min
and exposure to Hyperfilm ECL (Amersham) until bands
were visible. For molecular mass standards BioRad Low
Molecular Weight markers, spectrin (246 kD and 280 kD,
a kind gift of Jeni Fordham) and MyHC (220 kD) were
used.
Primary culture of rat skin cells
Newborn rat (P0–P3) skin was stretched and flattened
dermis-side down and incubated in 2% trypsin, PBS at
37°C for 1 hr and then for 4 hr at room temperature. Epi-
dermis was separated from dermis and each part of the
dissected skin was minced finely with scissors in Eagle's
minimal essential medium, 1.8 mM Ca2+, 10%FCS at 4°C
and stirred for 15 min to release cells from the epidermal
and dermal sheet mechanically. The cell suspension was
filtered through Nytex gauze, centrifuged at 500 rpm
(Beckman TJ-6) for 5 min at 4°C and re-suspended in
MEM 1.3 mM CaCl2, 10%FCS. Cells were plated at about
105cells/well on Nunc chamber slides which had been
coated with poly D-lysine (10 µg/ml, 100 µl/well 2 hours
at room temperature) followed by laminin (5 µg/ml, 100
µl/well 2 hours at 37°C) and BSA (1%, 100 µl/well for 15
min at 37°C). After 1–2 days culture, cells were fixed with
-20°C methanol for 2 min prior to immuno-detection of
antigens.
Neonatal rat cardiomyocyte culture
Hearts from newborn rats were digested with collagenase
(108 U/ml, Worthington Biochemical Corp., Freehold,
NJ, USA) in ADS buffer (116 mM NaCl, 20 mM HEPES,
0.8 mM NaH2PO4, 1 g/l glucose, 5.4 mM KCl, 0.8 mM
MgSO4; pH 7.35) and cultured as described [38]. Cells
were plated into dishes coated with 10 µg/ml fibronectin
in plating medium (67% Dulbecco's MEM (Amimed AG,
Basel, Switzerland), 17% Medium M199 (Amimed AG),
10% horse serum (Gibco, Life Technologies, Basel, Swit-
zerland), 5% fetal calf serum (Gibco) and 1% penicillin/
streptomycin (Gibco)). After one day the medium was
replaced by maintenance medium (78% Dulbecco's
MEM, 20% Medium M199, 1% penicillin/streptomycin,
1% horse serum and 10-4M phenylephrine (Sigma)).
Immunofluorescent stainings were performed as
described previously [22] using mouse monoclonal anti-
plakoglobin (γ-catenin) from Transduction Laboratories,
distributed by Maechler, Basel, Switzerland; polyclonal
rabbit anti-desmoplakin generously donated by Alison J
North, University of Manchester, UK; polyclonal rabbit
anti-pan-cadherin and FITC anti-mouse IgM (µ-chain spe-
cific) from Sigma, Buchs, Switzerland; TRITC anti-mouse
IgG (gamma-chain specific) from Cappel, distr. Organon
Technika, Pfaeffikon, Switzerland and Cy5 anti-rabbit IgG
from Jackson laboratories, distr. Milan, La Roche, Switzer-
land. Confocal images were recorded using a Leica PL
APO 63x/1.4 oil immersion lens on a Leica inverted
microscope DM IRB/E equipped with a Leica true confocal
scanner TCS NT and an argon/krypton mixed gas laser.
Image processing was performed on a Silicon Graphics
workstation using "Imaris" (Bitplane AG, Zurich,
Switzerland).
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